<?xml version="1.0" encoding="UTF-8"?><oembed><type>video</type><version>1.0</version><html>&lt;iframe src=&quot;https://www.loom.com/embed/1567cbaffeb24976b113172cf33e14b1&quot; frameborder=&quot;0&quot; width=&quot;1280&quot; height=&quot;960&quot; webkitallowfullscreen mozallowfullscreen allowfullscreen&gt;&lt;/iframe&gt;</html><height>960</height><width>1280</width><provider_name>Loom</provider_name><provider_url>https://www.loom.com</provider_url><thumbnail_height>960</thumbnail_height><thumbnail_width>1280</thumbnail_width><thumbnail_url>https://cdn.loom.com/sessions/thumbnails/1567cbaffeb24976b113172cf33e14b1-9546ef2de6bdc491.gif</thumbnail_url><duration>407.6</duration><title>The Testosterone Gap for Women After Menopause</title><description>This Loom discusses testosterone replacement for women, focusing on why unregulated hormone pellets are dangerous. It explains that testosterone is essential for women, but the United States has zero FDA approved commercial testosterone for women, contributing to a lucrative shadow market. The video claims compounded pellet users average about 193 nanograms per deciliter and can exceed 1,000, far above the typical 15 to 70 range, and warns this can lead to masculinizing side effects, abnormal uterine bleeding in over 55%, and more than three times the likelihood of hysterectomy. It contrasts pellets with FDA regulated transdermal gels, which can be precisely dosed, monitored with blood tests, stopped if no improvement after 3 to 4 months, and removed immediately, unlike pellets that cannot be removed for 4 to 6 months.</description></oembed>